Trial intelligence / Profile preview

Metformin in Pre-operative NSCLC (Lung Metcore Study)

NCT03086733Phase 2Completed

Sponsor
University Health Network
Start
Dec 2016
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin in non-small cell lung cancer (NSCLC), sponsored by University Health Network. Started Dec 2016; status: completed.

02

Drugs

metformin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT03086733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03086733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call